Cola as a quick fix for esophageal blockages in cancer patients?
NCT ID NCT06652620
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether drinking cola can help relieve sudden food blockages in the esophagus for people with esophageal cancer. Fifty participants will be randomly assigned to drink cola or receive standard care, and researchers will check if the blockage clears within 24 hours. The goal is to find a simple, non-invasive way to manage this common and distressing problem.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cola (Coca-Cola or Pepsi-Cola)
What this could lead to
If it works, this could provide a simple, at-home remedy to quickly relieve food blockages in esophageal cancer patients, avoiding emergency procedures.
What could go wrong
This is a small, early-stage trial with only 50 participants, so results may not apply to everyone. Cola might not work for all blockages, and there is a risk of aspiration or worsening symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First People's Hospital
Jingdezhen, Jiangxi, China
-
Fudan University Shanghai Cancer Center
Shanghai, 200032, China
-
Fudan University Shanghai Cancer Center Xiamen Hospital
Xiamen, Fujian, China
-
The Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, 225001, China